These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 15633102
21. Norepinephrine increases blood pressure but not survival with anthrax lethal toxin in rats. Li Y, Cui X, Su J, Haley M, Macarthur H, Sherer K, Moayeri M, Leppla SH, Fitz Y, Eichacker PQ. Crit Care Med; 2009 Apr; 37(4):1348-54. PubMed ID: 19242337 [Abstract] [Full Text] [Related]
22. The cytotoxic effect of anthrax lethal toxin on human lung cells in vitro and the protective action of bovine antibodies to PA and LF. Paddle BM, Wong VK, Muller BD. J Appl Toxicol; 2006 Apr; 26(2):162-8. PubMed ID: 16278807 [Abstract] [Full Text] [Related]
23. Catalytically inactive anthrax toxin(s) are potential prophylactic agents. Gupta M, Alam S, Bhatnagar R. Vaccine; 2007 Dec 05; 25(50):8410-9. PubMed ID: 17980467 [Abstract] [Full Text] [Related]
24. A phase 1 study of PAmAb, a fully human monoclonal antibody against Bacillus anthracis protective antigen, in healthy volunteers. Subramanian GM, Cronin PW, Poley G, Weinstein A, Stoughton SM, Zhong J, Ou Y, Zmuda JF, Osborn BL, Freimuth WW. Clin Infect Dis; 2005 Jul 01; 41(1):12-20. PubMed ID: 15937757 [Abstract] [Full Text] [Related]
25. Passive immunotherapy for anthrax toxin mediated by an adenovirus expressing an anti-protective antigen single-chain antibody. Kasuya K, Boyer JL, Tan Y, Alipui DO, Hackett NR, Crystal RG. Mol Ther; 2005 Feb 01; 11(2):237-44. PubMed ID: 15668135 [Abstract] [Full Text] [Related]
26. Mapping of antibody responses to the protective antigen of Bacillus anthracis by flow cytometric analysis. Reed DS, Smoll J, Gibbs P, Little SF. Cytometry; 2002 Sep 01; 49(1):1-7. PubMed ID: 12210604 [Abstract] [Full Text] [Related]
27. Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components. Mendelson I, Gat O, Aloni-Grinstein R, Altboum Z, Inbar I, Kronman C, Bar-Haim E, Cohen S, Velan B, Shafferman A. Vaccine; 2005 Dec 01; 23(48-49):5688-97. PubMed ID: 16039760 [Abstract] [Full Text] [Related]
28. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits. Wimer-Mackin S, Hinchcliffe M, Petrie CR, Warwood SJ, Tino WT, Williams MS, Stenz JP, Cheff A, Richardson C. Vaccine; 2006 May 01; 24(18):3953-63. PubMed ID: 16530302 [Abstract] [Full Text] [Related]
29. A human antibody against anthrax protective antigen protects rabbits from lethal infection with aerosolized spores. Wild MA, Kumor K, Nolan MJ, Lockman H, Bowdish KS. Hum Antibodies; 2007 May 01; 16(3-4):99-105. PubMed ID: 18334745 [Abstract] [Full Text] [Related]
33. Anthrax lethal toxin (LeTx) neutralization by PA domain specific antisera. Verma M, Suryanarayana N, Tuteja U, Thavachelvam K, Rao MK, Bhargava R, Shukla S. Toxicon; 2017 Dec 01; 139():58-65. PubMed ID: 28919458 [Abstract] [Full Text] [Related]
38. Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens. Sloat BR, Shaker DS, Le UM, Cui Z. FEMS Immunol Med Microbiol; 2008 Mar 01; 52(2):169-79. PubMed ID: 18194342 [Abstract] [Full Text] [Related]
40. Generation of mouse polyclonal and human monoclonal antibodies against Bacillus anthracis toxin. Huber M, Vor Dem Esche U, Grunow R, Bessler WG. Drugs Exp Clin Res; 2005 Mar 01; 31(2):35-43. PubMed ID: 15929604 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]